A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics (PK) after a Single Inhaled Dose when Administered using the Dry Powder Inhaler in Healthy Volunteers

Trial Identifier:	D3741C00006
Sponsor:	AstraZeneca
NCTID::	NCT02928354
Start Date:	November 2016
Primary Completion Date:	March 2017
Study Completion Date:	March 2017
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English translation
	German translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Germany	Berlin, Germany, 14050

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.